GL1X · GenesisL1 explorer

Research workbench

Identification of 2-(4-PYRIDYL)THIENOPYRIDINONES as gsk-3BETA inhibitors

Analyse Identification of 2-(4-PYRIDYL)THIENOPYRIDINONES as gsk-3BETA inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZRL
Type
protein
Length
740 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta; Proto-oncogene FRAT1
EC
2.7.11.26
UniProt
P49841, Q92837
Ligands
ZRL, SO4
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 4 distinct chains · 37% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26)protein34735% helix, 19% strandP49841
BGlycogen synthase kinase-3 beta (EC 2.7.11.26)protein34834% helix, 19% strandP49841
XProto-oncogene FRAT1protein2378% helix, 0% strandQ92837
YProto-oncogene FRAT1protein2277% helix, 0% strandQ92837

Ligands and binding sites

  • ZRL · 7-bromo-2-pyridin-4-yl-5H-thieno[3,2-c]pyridin-4-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111000.740.77103empty
22190.600.8025ZRL
32550.590.7925GOL, ZRL
41450.420.7530empty
5550.400.8113empty

Interfaces

3 interfaces between chains.

  • A–B · 894 Ų buried · 11 hydrogen bonds · protein-protein
  • A–X · 797 Ų buried · 6 hydrogen bonds · protein-protein
  • B–Y · 758 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 3ZRL · Identification of 2-(4-pyridyl)thienopyridi s as GSK-3beta inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92837 · AlphaFold monomer V2.0 prediction for proto-oncogene FRAT1 (Q92837) · a predicted model of the same protein · chain X against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.